adctherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wp-content/uploads/2021/05/CO_Disclosure_5.6.21.pdf Disallow:
Meta Tags
Title Antibody Drug Conjugates Cancer Treatment – ADC
Description Innovating Science. Inspiring ADC Therapeutics is a commercial-stage oncology-focused biotechnology company developing ADCs for patients with hematological malignancies & solid
Keywords N/A
Server Information
WebSite adctherapeutics faviconadctherapeutics.com
Host IP 13.92.117.44
Location United States
Related Websites
Site Rank
More to Explore
astronight.com
chinhvuong.com
cyrax.io
digitaltribegames.com
ergoteacher.com
filtonpackaging.com.au
imba.co
img999.com
lindsayliedke.com
listflatfeeonmls.com
lycheesonline.com
onlybags.com
sonygroup.com.au
tonkin-group.com
vinaleds.com
vinfastchevroletthanhhoa.com
zeroz-x.com
vlada.info
belmakosmetik.com
iranspicery.com
adctherapeutics.com Valuation
US$41,994,537
Last updated: 2023-05-07 01:43:10

adctherapeutics.com has Semrush global rank of 252,040. adctherapeutics.com has an estimated worth of US$ 41,994,537, based on its estimated Ads revenue. adctherapeutics.com receives approximately 4,845,524 unique visitors each day. Its web server is located in United States, with IP address 13.92.117.44. According to SiteAdvisor, adctherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$41,994,537
Daily Ads Revenue US$38,765
Monthly Ads Revenue US$1,162,926
Yearly Ads Revenue US$13,955,108
Daily Unique Visitors 323,035
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
adctherapeutics.com. A 300 IP: 13.92.117.44
adctherapeutics.com. NS 86400 NS Record: ns-1146.awsdns-15.org.
adctherapeutics.com. NS 86400 NS Record: ns-1966.awsdns-53.co.uk.
adctherapeutics.com. NS 86400 NS Record: ns-301.awsdns-37.com.
adctherapeutics.com. NS 86400 NS Record: ns-596.awsdns-10.net.
adctherapeutics.com. MX 300 MX Record: 10 us-smtp-inbound-2.mimecast.com.
adctherapeutics.com. MX 300 MX Record: 10 us-smtp-inbound-1.mimecast.com.
adctherapeutics.com. TXT 300 TXT Record: ZOOM_verify_Il4TIZSvQOSFwyPJY09lRQ
adctherapeutics.com. TXT 300 TXT Record: apple-domain-verification=6HeGTX5H6uptG7OL
adctherapeutics.com. TXT 300 TXT Record: google-site-verification=9Xa5DWCxZuj0RF4EaNhqK2_SbsnOASPqPu5X5JU1zPU
adctherapeutics.com. TXT 300 TXT Record: snn9q1nophu0amhtcbr80vsshs
adctherapeutics.com. TXT 300 TXT Record: v=spf1 include:us._netblocks.mimecast.com ip4:52.29.180.68 ip4:85.218.101.138 include:spf.protection.outlook.com -all
adctherapeutics.com. TXT 300 TXT Record: 9R033B670RDNDKOHDVN2HN8IMR
HtmlToTextCheckTime:2023-05-07 01:43:10
EXPLORE OUR VIRTUAL CONGRESS EXPERIENCE Investors Hit enter to search or ESC to close Menu About ADCT Overview Vision and Values Our Leadership Team Our Board of Directors Partnering Charitable Contributions & Sponsorships Responsibility Products ZYNLONTA ® (loncastuximab tesirine-lpyl) Pipeline Overview loncastuximab tesirine-lpyl camidanlumab tesirine ADCT-602 Mipasetamab uzoptirine (ADCT-601) ADCT-901 ADCT-701 ADCT-212 Science Overview Our Technology Medical Affairs Overview Research and Educational Grants Early Access Inquiries Careers Now Approved! ZYNLONTA ® Added to Clinical Guidelines Explore Our Virtual Congress Experience ZYNLONTA ® Added to Clinical Guidelines --> Innovating Science. Inspiring Hope. CAREERS David Gilman – Chief Business & Strategy Officer Hear how David Gilman’s personal journey inspired him to join ADC Therapeutics. LATEST NEWS Our Annual Report on Form 20-F for the fiscal year ended December 31, 2022, has been filed with the U.S. Securities and
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 02:12:26 GMT
Server: Apache/2.4.37 (Red Hat Enterprise Linux) OpenSSL/1.1.1c
Location: https://www.adctherapeutics.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 200 OK
Date: Wed, 27 Oct 2021 02:12:27 GMT
Server: Apache/2.4.37 (Red Hat Enterprise Linux) OpenSSL/1.1.1c
X-Powered-By: PHP/7.4.19
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate
Pragma: no-cache
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Set-Cookie: PHPSESSID=9g6ibe3o4h6hjldpjh8d5pgko5; path=/
Content-Type: text/html; charset=UTF-8
adctherapeutics.com Whois Information
Domain Name: ADCTHERAPEUTICS.COM
Registry Domain ID: 1695944516_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2016-08-14T02:04:18Z
Creation Date: 2012-01-08T06:09:31Z
Registry Expiry Date: 2022-01-08T06:09:31Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS-1146.AWSDNS-15.ORG
Name Server: NS-1966.AWSDNS-53.CO.UK
Name Server: NS-301.AWSDNS-37.COM
Name Server: NS-596.AWSDNS-10.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T00:41:47Z <<<